Sunrun Short Interest Hits a Year-High as the Stock Surges 15%
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
Short sellers have built their largest position in Sunrun in at least a year, even as the stock posted one of its best weeks in recent memory.
Short interest reached 31.2% of free float on November 3, up from roughly 29.4% a month ago and the highest reading in the data window. The position has grown steadily: shares short climbed from around 69.8 million at the start of October to 72.3 million by week's end, a rise of roughly 3.5% over the past month. With days-to-cover running at 8.6 based on the latest FINRA fortnightly data, unwinding the short book is not a quick exercise.
The lending market tells a different story from the short interest headline. Borrow availability is running at 340%, meaning there are more than three shares available to lend for every one already borrowed. That is well above the 52-week floor of 211%. The cost to borrow has also eased, dropping around 17% over the past week to 0.42%, a level that offers no meaningful friction to anyone wanting to maintain or add a short position. Put differently, the bears are numerous but not squeezed: the borrow market is accommodating. Options positioning sits close to neutral, with the put/call ratio at 0.62, only slightly above its 20-day average of 0.59, leaving the z-score near zero and well below any defensive extreme.
The shares moved in the opposite direction from the shorts this week, rising 15.3% to $8.68. That is more than double the median gain of around 6% posted by Sunrun's closest peers over the same period. ARRY led the peer group with a 36.9% weekly gain, while SHLS added 13.3% and GNRC rose 8%. Sunrun's move was therefore meaningful in absolute terms but not an outlier when the whole clean-energy complex is being bid up.
The analyst community has spent October cutting price targets without changing ratings. JPMorgan trimmed to $12 from $14 while keeping Overweight. Goldman Sachs lowered to $11 from $13, also retaining Buy. Morgan Stanley cut to $10 from $15 at Equal-Weight. The pattern is consistent across the Street: confidence in the direction of the business but less certainty about the valuation it deserves. The mean target, now clustered in the $10 to $14 range, still sits above the current price of $8.68, though the gap between the most bearish published target, GLJ Research's $4.63 Sell, and the most optimistic framing reflects genuine disagreement about whether Sunrun's $1.0 to $1.3 billion net value creation guidance is achievable. The EV/EBITDA multiple has compressed by roughly two turns over the past 30 days to around 19.6x, tracking the share price move in both directions.
Insider activity from early October adds texture. On October 6, CEO Mary Powell sold 24,335 shares at $7.76 for proceeds of roughly $189,000, without a declared 10b5-1 plan. The CFO, COO, Chief Legal Officer, and Chief Accounting Officer also sold on the same day, all at similar prices. The coordinated nature of the sales on a single date, without pre-arranged trading plans in most cases, is worth noting. Net insider sales over the 90 days through October 6 totalled approximately $1.07 million across 122,000 shares. No open-market purchases appear in the record over that period.
Sunrun reports earnings on November 4, with the last two prints producing a next-day decline of 15% and a gain of 10% respectively, leaving the range of outcomes wide. Short interest at a year-high, borrow costs low, and insider selling clustered near the recent price low are the data points going into the release.
Stocks in this article
See the live data behind this article on ORTEX.
Open RUN on ORTEX →How this article was generated
- Generated
- 4 Nov 2026, 20:05
- Data as of
- 4 Nov 2026, 20:04
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt Data
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.